Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
Latest Information Update: 03 Sep 2024
At a glance
- Drugs Duloxetine (Primary) ; Escitalopram (Primary) ; Clonazepam; Pregabalin
- Indications Anxiety disorders; Generalised anxiety disorder; Panic disorder; Social phobia
- Focus Therapeutic Use
- Acronyms DOTS-AD
Most Recent Events
- 29 Aug 2024 Planned End Date changed from 31 Dec 2024 to 31 Dec 2025.
- 29 Aug 2024 Planned primary completion date changed from 30 Jul 2024 to 30 Jul 2025.
- 11 Feb 2020 New trial record